Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Synthesis and Manufacturing Services Market (2nd Edition), 2022–2035”
The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes
- A general overview of mRNA, highlighting details on its structure, the evolution of mRNA vaccines, manufacturing processes and commonly outsourced manufacturing operations.
- A detailed assessment of the overall market landscape of the companies offering mRNA custom synthesis services.
- A detailed competitiveness analysis of mRNA custom synthesis service providers.
- A comprehensive assessment of the overall market landscape of mRNA contract manufacturing service providers, based on several relevant parameters.
- An in-depth company competitiveness analysis of mRNA contract manufacturing service providers based in North America, Europe and Asia-Pacific.
- A detailed overview of the current market landscape of kits available for synthesis of research grade mRNA.
- A detailed product competitiveness analysis of the mRNA synthesis kits.
- Elaborate profiles of key players engaged in the synthesis and manufacturing of mRNA (shortlisted based on strength of service portfolio).
- Detailed profiles of the key mRNA synthesis kit providers (shortlisted based on strength of product portfolio).
- A detailed assessment of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines.
- An insight analysis of the recent partnerships inked between stakeholders engaged in this domain from 2014-2022
- An in-depth analysis of over 35 mRNA-based therapeutics / vaccines developers that are likely to partner with mRNA contract manufacturing service providers.
- A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021)
- A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
- Type of Product
- Drug substances (APIs)
- Drug products (FDFs)
- Application Area
- mRNA-based vaccines
- mRNA-based therapeutics
- Therapeutic Area
- Infectious diseases
- Oncological disorders
- Other diseases
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and North Africa
- Rest of the World
Key companies covered in the report.
- Aldevron
- APExBIO
- Biomay
- bioSYNTHESIS
- CELLSCRIPT
- eTheRNA
- Eurogentec
- Jena Biosciences
- New England Biolabs
- Thermo Fisher Scientific
- TriLink BioTechnologies
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html
You may also be interested in the following titles:
Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space
Medical Device Coatings Market
Roots Analysis Consulting - the preferred research partner for global firms
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
